GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 2,311.50
-17.70 (-0.76%)
Apr 2, 2026, 3:30 PM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 391.4 billion as of April 2, 2026. Its market cap has decreased by -13.00% in one year.
Market Cap
391.40B
Enterprise Value
371.15B
Revenue
38.01B
Ranking
n/a
PE Ratio
38.34
Stock Price
2,311.50
Market Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 391.40B, an increase of 1,944.95%. That is a compound annual growth rate of 13.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 391.40B | -6.50% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.57T |
| Apollo Hospitals Enterprise | 1.05T |
| Cipla | 966.03B |
| Ipca Laboratories | 382.64B |
| Anthem Biosciences | 373.86B |
| Aster DM Healthcare | 355.52B |
| Ajanta Pharma | 351.78B |